Recent Posts
- Illinois Attorney General Files Lawsuit Against HIV/AIDS Nonprofit
- California Gov. Arnold Schwarzenegger Signs Budget That Cuts $52M From HIV/AIDS Programs
- Efforts Underway In Namibia To Treat Pediatric HIV
- HIV/AIDS Education Project Targeting Pennsylvania Black Women Examined
- Also In Global Health News: Uganda Male Circumcision; Malaria Vaccine; Potential Global Fund Grant In Cambodia; PMTCT Of HIV In Botswana
Random Posts
- Prime-Boost Vaccine Study Shows Modest Effect In Preventing HIV
- HIV Vaccine Shows Promise In Trial
- Gilead Sciences, Tibotec To Develop Second Once-Daily HIV Treatment
- Review Of Brazil's HIV/AIDS Treatment Programs Shows Importance Of Generic Drugs, Researchers Say
- African Health Ministers Adopt Resolutions To Improve Health As WHO Regional Meeting Closes
- Groundbreaking DKT/TOTAL Ethiopia Initiative To Promote Condoms To Housemaids Launched
- Yale And University Of Malaya Join Forces To Battle HIV In Prisons
- THT's One-hour 'Fastest' Service Aims To Reduce Undiagnosed HIV In Brighton & Hove
- CDC Issues Fact Sheet On Oral Sex, HIV Transmission
- CONRAD Executive Director To Give Guttmacher Lecture At Reproductive Health 2009
Prescription AIDS Drugs
Contact Us
Further Progress Toward AIDS Vaccine
March 18th, 2010
Researchers from Thomas Jefferson University are one step closer to developing a vaccine against the AIDS disease.
Led by Matthias J. Schnell, Ph.D., director of the Jefferson Vaccine Center, the researchers found that a rabies virus-based vaccine administered to monkeys protected against the simian equivalent of the HIV virus (SIV). The data were published in the journal Vaccine.
The researchers previously showed that a rabies-based vaccine expressing HIV and SIV antigens protective against a chimeric HIV/SIV virus in monkeys. In this study, they used highly attenuated rabies virus vaccine vectors to protect against challenge with the highly pathogenic SIVmac251. This type of SIV virus causes a more similar disease in monkeys compared to human infection with HIV-1. In addition, it is difficult to protect monkeys against AIDS-like disease after challenge with SIVmac251.
Two vaccine strategies were used: immunization with a recombinant rabies virus expressing SIVmac239GagPol, or a combination of that and a rabies virus expressing SIVmac239Env. Both strategies induced neutralizing antibody production, CD8+ T cell responses, and increased protection. Although the combination with Env helped immediately following the infection, the long-term benefits were minimal. However, it was surprising that the rabies-based vaccine was able to induce such potent anti-SIV humoral responses.
“Although we can’t yet block the infection, we showed that we can protect against disease,” said Dr. Schnell. “We also saw significant antibody activity against the virus, which is promising. In addition, this is a very simple approach that only took two immunizations.”
Source: Emily Shafer
Thomas Jefferson University
Related posts:
- Gene Transfer Technology May Lead To HIV Vaccine A research team may have broken the impasse that has...
- Researchers Develop Vaccine Candidate That Is Successful In Blocking Simian Version Of HIV Researchers have successfully blocked SIV, the simian version of HIV,...
- Leading Vaccine Discovery Expert Joins The International AIDS Vaccine Initiative (IAVI) Dr. C. Richter (Rick) King, former Senior Vice President of...
- New Advances On The Long Road To The Development Of An AIDS Vaccine AIDS Vaccine Day, May 18, marks the occasion in 1997...
- Binding Action Of 2 Key HIV Antibodies Could Lead To New Vaccine Design A very close and detailed study of how the most...
Related posts brought to you by Yet Another Related Posts Plugin.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.